ConvaTec Inc.
$9.3M 12,574 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
W. L. Gore & Associates, Inc.
W. L. Gore & Associates, Inc. reported $9,470,598.27 across General Payments, Research, and Ownership to 25,860 physicians and teaching hospitals across 26,712 transactions.
- $9.5M Top 10% payer
- All-tracks total
- 26,712 Top 10% volume
- Transactions
- 25,860 Top 10% reach
- Recipients
- −$272.8K
- General Payments vs PY2023
W. L. Gore & Associates, Inc. reported $9,470,598.27 across all CMS Open Payments tracks (General + Research + Ownership) to 25,860 physicians and teaching hospitals in Program Year 2024 - ranking #182 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $5,364,781.69, averaging $366.23 per recipient.
How W. L. Gore & Associates, Inc.'s $9.5M all-tracks total breaks down
W. L. Gore & Associates, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
A
97/100
Total payments
A
98/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
A
90/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer w-l-gore-associates-inc W. L. Gore & Associates, Inc.
$9.5M · #182/1,925 · 0.1% industry · PY2024
- TOT $9.5M
- RANK #182
- SHARE 0.1%
- TXN 26,712
- RCP 25,860
- CAT 7
- GEN $5.4M
- ΔGEN −$272.8K
- TOP1 3.1%
- PY 2024
Volume peers
Nearest volume peer: ConvaTec Inc. ($9.3M)
W. L. Gore & Associates, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
W. L. Gore & Associates, Inc.'s CMS-reported General Payments decreased by $272.8K (−4.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: W. L. GORE & ASSOCIATES, INC.PY2023: W. L. GORE & ASSOCIATES, INC.PY2024: W. L. Gore & Associates, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $5,637,539.68
- PY2024
- $5,364,781.69
What the Data Shows for W. L. Gore & Associates, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For W. L. Gore & Associates, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 7-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $2.8M, accounting for 51.9% of this company's General Payments and 1,121 transactions.
General Payment Breakdown by Type
W. L. Gore & Associates, Inc. made 7 types of general payments. "Consulting Fee" is the largest category at $2.8M, 51.9% of General Payments.
W. L. Gore & Associates, Inc. reports 7 general-payment categories - the top three are Consulting Fee (51.9%), Food and Beverage (24.4%), and Travel and Lodging (13.8%). The remaining 4 categories make up 10.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How W. L. Gore & Associates, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $2.8M | 1,121 | 51.9% |
| Food and Beverage | $1.3M | 20,028 | 24.4% |
| Travel and Lodging | $737.8K | 3,003 | 13.8% |
| Grant | $465.1K | 23 | 8.7% |
| Education | $61.1K | 1,651 | 1.1% |
| Compensation for Services Other Than Consulting | $7.2K | 13 | 0.1% |
| Honoraria | $2.3K | 21 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $507,211.47 (9.5%) of $5,364,781.69 in this company's General Payments records across 7,324 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for W. L. Gore & Associates, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Esen Akpek
$163,864.28 across 51 reported transactions
- 2
Mount Sinai Hospital
$100,000.00 across 1 reported transactions
- 3
Cedars-Sinai Medical Center
$82,500.00 across 2 reported transactions
- 4
John Linn
$81,364.70 across 79 reported transactions
- 5
Brant Ullery
$79,482.49 across 123 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
W. L. Gore & Associates, Inc. ranks #182 of 1,925 by total payments (top 9% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,766 of 1,838 by HHI (bottom 4% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Mylan Specialty L.P. : $1.4M total payments, HHI 51
- Virtus Pharmaceuticals LLC : $19.8K total payments, HHI 50
- Madrigal Pharmaceuticals : $4.5M total payments, HHI 49
- Electronic Waveform Lab, Inc. : $32.0K total payments, HHI 47
- Avvisto Therapeutics, LLC : $8.9K total payments, HHI 47
- Neurocrine Biosciences, Inc. : $14.2M total payments, HHI 47
- W. L. Gore & Associates, Inc. (this company) : $5.4M total payments, HHI 47
- Aucta Pharmaceuticals, Inc. : $25.2K total payments, HHI 46
- Axsome Therapeutics, Inc. : $12.2M total payments, HHI 45
- Sumitomo Pharma America, Inc. : $3.8M total payments, HHI 45
- Phathom Pharmaceuticals, Inc. : $10.7M total payments, HHI 45
- Sun Pharmaceutical Industries Inc. : $6.3M total payments, HHI 45
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as W. L. Gore & Associates, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about W. L. Gore & Associates, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with W. L. Gore & Associates, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
EyePoint Pharmaceuticals US, Inc.
$9.7M 748 recipients
Compare payment profiles
Route 92 Medical, Inc.
$9.7M 774 recipients
Compare payment profiles
Dermavant Sciences, Inc.
$9.7M 73,486 recipients
Compare payment profiles
Eli Lilly Export S.A. Puerto Rico Branch
$9.2M 1,317 recipients
Compare payment profiles
Supernus Pharmaceuticals, Inc.
$9.7M 61,253 recipients
Compare payment profiles
Put this to use
W. L. Gore & Associates, Inc. ranks #182 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where W. L. Gore & Associates, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just W. L. Gore & Associates, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.